1h Free Analyst Time
The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Drugs In Development 2022, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.Speak directly to the analyst to clarify any post sales queries you may have.
Non-Hodgkin lymphoma (also known as non-Hodgkin's lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of the body's immune system. Symptoms depend on what area of the body is affected by the cancer and how fast the cancer is growing. Symptoms may include night sweats (soaking the bed sheets and pajamas even though the room temperature is not too hot),fever and chills that come and go, itching, swollen lymph nodes in the neck, underarms, groin, or other areas, weight loss, coughing or shortness of breath if the cancer affects the thymus gland or lymph nodes in the chest, putting pressure on the windpipe (trachea) or other airway, abdominal pain or swelling, leading to loss of appetite, constipation, nausea, and vomiting and headache, concentration problems, personality changes, or seizures if the cancer affects the brain. Treatment includes surgery, radiation therapy and chemotherapy.
Report Highlights
The publisher's Pharmaceutical and Healthcare latest pipeline guide Non-Hodgkin Lymphoma - Drugs In Development 2022, provides comprehensive information on the therapeutics under development for Non-Hodgkin Lymphoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Non-Hodgkin Lymphoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Non-Hodgkin Lymphoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 24, 3, 39, 262, 277, 16, 41, 220, 43 and 4 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages comprises 36, 51, 4, 43, 6 and 1 molecules, respectively.
Non-Hodgkin Lymphoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Non-Hodgkin Lymphoma (Oncology).
- The pipeline guide reviews pipeline therapeutics for Non-Hodgkin Lymphoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Non-Hodgkin Lymphoma (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Non-Hodgkin Lymphoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Non-Hodgkin Lymphoma (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Non-Hodgkin Lymphoma (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Non-Hodgkin Lymphoma (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
- Introduction
- Report Coverage
- Non-Hodgkin Lymphoma - Overview
- Non-Hodgkin Lymphoma - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Non-Hodgkin Lymphoma - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Non-Hodgkin Lymphoma - Companies Involved in Therapeutics Development
- Non-Hodgkin Lymphoma - Drug Profiles
- Non-Hodgkin Lymphoma - Dormant Projects
- Non-Hodgkin Lymphoma - Discontinued Products
- Non-Hodgkin Lymphoma - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact the Publisher
- Disclaimer
- Number of Products under Development for Non-Hodgkin Lymphoma, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Products under Development by Companies, 2022
- Products under Development by Universities/Institutes, 2022
- Number of Products by Stage and Target, 2022
- Number of Products by Stage and Mechanism of Action, 2022
- Number of Products by Stage and Route of Administration, 2022
- Number of Products by Stage and Molecule Type, 2022
- Non-Hodgkin Lymphoma - Dormant Projects, 2022
- Non-Hodgkin Lymphoma - Discontinued Products, 2022
- Number of Products under Development for Non-Hodgkin Lymphoma, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Number of Products by Top 10 Targets, 2022
- Number of Products by Stage and Top 10 Targets, 2022
- Number of Products by Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Mechanism of Actions, 2022
- Number of Products by Top 10 Routes of Administration, 2022
- Number of Products by Stage and Top 10 Routes of Administration, 2022
- Number of Products by Top 10 Molecule Types, 2022
- Number of Products by Stage and Top 10 Molecule Types, 2022
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 2Seventy Bio Inc
- 3SBio Inc
- 4SC AG
- A. Menarini Industrie Farmaceutiche Riunite Srl
- AB Science SA
- AbbVie Inc
- Abclon Inc
- Abologix Sarl
- Acepodia Inc
- Acerta Pharma BV
- Achelois Cell Therapy
- Actinium Pharmaceuticals Inc
- Actinobac Biomed Inc
- Adagene Suzhou Ltd
- ADC Therapeutics SA
- Adicet Bio Inc
- Adienne Pharma & Biotech SA
- Adlai Nortye Biopharma Co Ltd
- Advenchen Laboratories LLC
- Affimed GmbH
- AI Therapeutics Inc
- Akeso Inc
- AKSO Biopharmaceutical Inc
- Alaunos Therapeutics Inc
- Aleta Biotherapeutics Inc
- Alexion Pharmaceuticals Inc
- Alfasigma SpA
- Allogene Therapeutics Inc
- Alphamab Oncology
- Alpine Immune Sciences Inc
- Altamira Therapeutics Ltd
- ALX Oncology Holdings Inc
- Amgen Inc
- Angimmune LLC
- Angiocrine Bioscience Inc
- Anhorn Medicines Co Ltd
- Anhui Anke Biotechnology (Group) Co Ltd
- Antengene Corp Ltd
- AP Biosciences Inc
- Apollomics Inc
- Apotex Inc
- Arcus Biosciences Inc
- Ardan Pharma
- Argenx SE
- Arvinas Inc
- Ascentage Pharma Group Inc
- Ascentage Pharma Group International
- Astellas Pharma Inc
- Astex Pharmaceuticals Inc
- AstraZeneca Plc
- Asylia Therapeutics Inc
- Atara Biotherapeutics Inc
- Athenex Inc
- Aurigene Discovery Technologies Ltd
- Autolus Therapeutics Plc
- Avalon GloboCare Corp
- Avesthagen Ltd
- Avipep Pty Ltd
- AVM Biotechnology LLC
- Avvinity Therapeutics Ltd
- Axter Therapeutics Ltd
- AzarGen Biotechnologies (Pty) Ltd
- BAKX Therapeutics Inc
- Bantam Pharmaceutical LLC
- Bayer AG
- BeiGene Ltd
- Beijing Cytoheal Biotech Co Ltd
- Beijing Gaobo Biotechnology Co Ltd
- Beijing GD Initiative Cell Therapy Technology Co Ltd
- Beijing Immunochina Pharmaceuticals Co Ltd
- Beijing Jingda Biotechnology Co Ltd
- Beijing Luzhu Biotechnology Co Ltd
- Beijing Mabworks Biotech Co Ltd
- Bellicum Pharmaceuticals Inc
- Betta Pharmaceuticals Co Ltd
- Bio-Path Holdings Inc
- Bio-Thera Solutions Ltd
- BioCurate Pty Ltd
- BioEclipse Therapeutics Inc
- Biogen Inc
- BioIntegrator
- BioInvent International AB
- BioLineRx Ltd
- Biomea Fusion Inc
- BioNTech SE
- BioPact Ventures LLC
- BioTheryX Inc
- BioXpress Therapeutics SA
- Bivictrix Therapeutics PLC
- Boehringer Ingelheim International GmbH
- Boryung Pharmaceutical Co Ltd
- Boryung ViGenCell Inc
- Bristol-Myers Squibb Co
- C4 Therapeutics Inc
- Calithera Biosciences Inc
- Caribou Biosciences Inc
- Carna Biosciences Inc
- Carrick Therapeutics Ltd
- CARsgen Therapeutics Ltd
- Cartherics Pty Ltd
- Catalent Inc
- Catapult Therapeutics BV
- Celdara Medical LLC
- Cell Source Inc
- Cell>Point LLC
- CellCentric Ltd
- Celldex Therapeutics Inc
- Cellectar Biosciences Inc
- Cellectis SA
- Cellenkos Inc
- Celleron Therapeutics Ltd
- Cellestia Biotech AG
- Celltrion Inc
- Cellular Biomedicine Group Inc
- Celularity Inc
- Centaurus Biopharma Co Ltd
- Centrose LLC
- Centrymed Pharmaceutical Inc
- Century Therapeutics Inc
- Ceptur Therapeutics Inc
- CerRx Inc
- CGeneTech (Suzhou China) Co Ltd
- Changzhou Qianhong Bio-Pharma Co Ltd
- Cheetah Cell Therapeutics Co Ltd
- Chengdu Brilliant Pharmaceutical Co Ltd
- Chengdu Hyperway Pharmaceutical Co Ltd
- Chengdu Jinrui Foundation Biotechnology Co Ltd
- Chengdu Zenitar Biomedical Technology Co Ltd
- Chia Tai Tianqing Pharmaceutical Group Co Ltd
- Chimagen Biosciences Ltd
- Chimeric Therapeutics Ltd
- China Immunotech Co Ltd
- Chineo Med Beijing Co Ltd
- CHO Pharma Inc
- Chongqing Precision Biotech Co Ltd
- Chugai Pharmaceutical Co Ltd
- Cielo Therapeutics Inc
- Clayton Biotechnologies Inc
- Clevexel Pharma SA
- Clonz Biotech Pvt Ltd
- Codiak BioSciences Inc
- CoImmune Inc
- Conjupro Biotherapeutics Inc
- Cornerstone Pharmaceuticals Inc
- Corvus Pharmaceuticals Inc
- Cothera Bioscience Pty Ltd
- CRISPR Therapeutics AG
- CrystalGenomics Inc
- CSL Ltd
- CSPC Pharmaceutical Group Ltd
- CStone Pharmaceuticals Co Ltd
- CTI BioPharma Corp
- Cullinan Oncology Inc
- Curis Inc
- Curocell Inc
- Curon Biopharmaceutical Ltd
- Cyclacel Pharmaceuticals Inc
- Cyteir Therapeutics Inc
- CytomX Therapeutics Inc
- Daiichi Sankyo Co Ltd
- Daysai Biopharmaceuticals Inc
- Dayton Therapeutics AG
- Debiopharm International SA
- DeepCure Inc
- DEKK-TEC Inc
- Denovo Biopharma LLC
- Dialectic Therapeutics Inc
- Dizal (Jiangsu) Pharmaceutical Co Ltd
- Dr. Reddy's Laboratories Ltd
- Dren Bio Inc
- Duet Therapeutics Inc
- EdiGene Inc
- eFFECTOR Therapeutics Inc
- Eisai Co Ltd
- Eli Lilly and Co
- Elicera Therapeutics AB
- Emergent BioSolutions Inc
- Emmaus Life Sciences Inc
- Enterome Bioscience SA
- Epidestiny Inc
- Epizyme Inc
- Equillium Inc
- Esanex Inc
- Estrella Biopharma Inc
- Eternity Bioscience Inc
- Eucure (Beijing) Biopharma Co Ltd
- Eureka Therapeutics Inc
- Eutilex Co Ltd
- Evopoint Bioscience Co Ltd
- Evotec SE
- Excelmab Inc
- Exelixis Inc
- Exinda Therapeutics LLC
- F-star Therapeutics Inc
- F. Hoffmann-La Roche Ltd
- FamiCordTx SA
- Fate Therapeutics Inc
- Fochon Pharmaceutical Ltd
- Fosun Kite Biotechnology Co Ltd
- Fresh Tracks Therapeutics Inc
- Fujifilm Holdings Corp
- FutureGen Biopharm Technology Co Ltd
- Galapagos NV
- Galderma SA
- Gamida Cell Ltd
- Geneius Biotechnology Inc
- Genentech USA Inc
- Geneos Therapeutics Inc
- GeneScience Pharmaceuticals Co Ltd
- Genexine Inc
- Genmab AS
- Genor BioPharma Co Ltd
- Genosco Inc
- Gibson Oncology LLC
- Gilead Sciences Inc
- Gossamer Bio Inc
- Gracell Biotechnologies Inc
- Green Cross LabCell Corp
- Greenfire Bio LLC
- Grupo Ferrer Internacional SA
- GSK plc
- GT Biopharma Inc
- Guangdong East Sunshine Pharmaceutical Co Ltd
- Guangdong Zhongsheng Pharmaceutical Co Ltd
- Guangzhou Bairui Biomedical Technology Co Ltd
- Guangzhou BeBetter Medicine Technology Co Ltd
- Guangzhou Bio-gene Technology Co Ltd
- Guangzhou Sinogen Pharmaceutical Co Ltd
- H3 Biomedicine Inc
- Haisco Pharmaceutical Group Co Ltd
- Hangzhou Hezheng Pharmaceutical Co Ltd
- Hangzhou Minsheng Pharmaceutical Group Co Ltd
- Hangzhou Rongu Biotechnology Co Ltd
- Hangzhou Sumgen Biotech Co Ltd
- Hangzhou Zenshine Pharmaceuticals Co Ltd
- Harbin Gloria Pharmaceuticals Co Ltd
- Hebei Senlang Biotechnology Co Ltd
- HEC Pharma Co Ltd
- Hefei Hankemab Biotechnology Co Ltd
- Heidelberg Pharma AG
- Helocyte Biosciences Inc
- Helsinn Group
- Hibercell Inc
- HK inno.N Corp
- HRAIN Biotechnology Co Ltd
- Hualan Biological Engineering Inc
- Hunan Siweikang Therapeutics Ltd
- Hutchison MediPharma Ltd
- I-Mab
- iBio Inc
- iCell Gene Therapeutics LLC
- IDP Discovery Pharma SL
- IGM Biosciences Inc
- Iksuda Therapeutics Ltd
- ImCheck Therapeutics SAS
- Immune Cell Inc
- ImmuneCyte Inc
- ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
- ImmuneTarget Inc
- Immunitas Therapeutics Inc
- ImmunityBio Inc
- ImmunoAct Pvt Ltd
- ImmunoGen Inc
- Immunomet Therapeutics Inc
- Immunotech Biopharm Ltd
- Impetis Biosciences Ltd
- IMV Inc
- Inatherys
- Incyte Corp
- Indaptus Therapeutics Inc
- Inflection Biosciences Ltd
- Innate Pharma SA
- InnoBation Bio
- InnoCare Pharma Ltd
- Innovative Cellular Therapeutics Co Ltd
- Innovent Biologics Inc
- Invion Ltd
- IO Biotech Inc
- iOnctura SA
- Ionis Pharmaceuticals Inc
- Iterion Therapeutics Inc
- Japan Tobacco Inc
- Jazz Pharmaceuticals Plc
- Jiangsu Carephar Pharmaceutical Co Ltd
- Jiangsu Hengrui Medicine Co Ltd
- Jiangsu Maidu Drug Research and Development Co Ltd
- Jing Medicine Technology Shanghai Ltd
- JN Biosciences LLC
- Johnson & Johnson
- Jubilant Therapeutics Inc
- Juventas Cell Therapy Ltd
- JW Cayman Therapeutics Co Ltd
- KAHR medical Ltd
- Kainos Medicine Inc
- Kangpu Biopharmaceuticals Ltd
- Kartos Therapeutics Inc
- Karus Therapeutics Ltd
- Karyopharm Therapeutics Inc
- Kecellitics Biotech Co Ltd
- Kesios Therapeutics Ltd
- Kezar Life Sciences Inc
- Kiniksa Pharmaceuticals Ltd
- Kiromic BioPharma Inc
- Kite Pharma Inc
- Klyss Biotech Inc
- Komipharm International Co Ltd
- Kronos Bio Inc
- Kymera Therapeutics Inc
- Kyowa Kirin Co Ltd
- Lantern Pharma Inc
- Lanzhou Institute of Biological Products Co Ltd
- Legend Biotech Corp
- LegoChem Biosciences Inc
- Lepton Pharmaceuticals Ltd
- Lepu Biopharma Co Ltd
- Les Laboratoires Servier SAS
- Light Chain Bioscience
- LintonPharm Co Ltd
- Livzon Pharmaceutical Group Co Ltd
- Loxo Oncology Inc
- LTZ Therapeutics Inc
- Luminary Therapeutics Inc
- Lupin Ltd
- Lyvgen Biopharma Ltd
- Mabion SA
- Mablink Bioscience
- Machavert Pharmaceuticals LLC
- MacroGenics Inc
- ManysmarT Therapeutics Inc
- Marino Biotechnology Co Ltd
- Marker Therapeutics Inc
- Meabco AS
- MedC Biopharma Ltd
- Medinet Co Ltd
- MediSix Therapeutics Pte Ltd
- Meditope Biosciences Inc
- Medivir AB
- MedPacto Inc
- MEI Pharma Inc
- MENTRIK Biotech LLC
- Merck & Co Inc
- Merck KGaA
- Millennium Pharmaceuticals Inc
- Miltenyi Biomedicine GmbH
- Minghui Pharmaceutical (Shanghai) Co Ltd
- MiNK Therapeutics Inc
- Mirati Therapeutics Inc
- MiRecule Inc
- Moderna Inc
- Molecular Templates Inc
- Moleculin Biotech Inc
- Monte Rosa Therapeutics Inc
- Morphiex Biotherapeutics Inc
- MorphoSys AG
- Multitude therapeutics Inc
- Mustang Bio Inc
- Myeloid Therapeutics Inc
- Nanjing Aimeifei Biomedical Technology Co Ltd
- Nanjing Bioheng Biotech Co Ltd
- Nanjing CART Medical Technology Co Ltd
- Nanjing Iaso Biotherapeutics Co Ltd
- Nanjing KAEDI Biotech Inc
- Nanjing Sanhome Pharmaceutical Co Ltd
- Nanjing Yoko Pharmaceutical Co Ltd
- Nanoligent SL
- Navrogen Inc
- Nektar Therapeutics
- Neoleukin Therapeutics Inc
- Neonc Technologies Inc
- Neumedicines Inc
- Newave Pharmaceutical Inc
- NewBio Therapeutics Inc
- Nichi-Iko Pharmaceutical Co Ltd
- Ningbo Wenda Pharmaceutical Technology Co Ltd
- Nkarta Inc
- Nordic Nanovector ASA
- Northlake International LLC
- NovalGen Ltd
- Novartis AG
- Numab Therapeutics AG
- Nurix Therapeutics Inc
- Nutcracker Therapeutics Inc
- Nuvalent Inc
- Onco Therapies Inc
- Onconova Therapeutics Inc
- Oncopeptides AB
- OncoTartis Inc
- Oncovir Inc
- Oncternal Therapeutics
- OnKure Inc
- Ono Pharmaceutical Co Ltd
- Orano Med LLC
- Orca Biosystems Inc
- ORIC Pharmaceuticals Inc
- Otsuka Pharmaceutical Co Ltd
- Oxcia AB
- Oxford BioTherapeutics Ltd
- Pacylex Pharmaceuticals Inc
- Pell Bio-Med Technology Co Ltd
- PeproMene Bio Inc
- PersonGen BioTherapeutics (Suzhou) Co Ltd
- Pfizer Inc
- Pharmapraxis
- Philogen SpA
- PIQUR Therapeutics AG
- Plexxikon Inc
- Precigen Inc
- Precision Biosciences Inc
- Prelude Therapeutics Inc
- Prescient Therapeutics Ltd
- ProfoundBio Suzhou Co Ltd
- Propanc Biopharma Inc
- Protheragen Inc
- Qilu Pharmaceutical Co Ltd
- Qilu Puget Sound Biotherapeutics Corp
- QLSF Biotherapeutics Inc
- Quimatryx SL
- Ranok Therapeutics Co Ltd
- RAPT Therapeutics Inc
- Refuge Biotechnologies Inc
- Regenacy Pharmaceuticals LLC
- Regeneron Pharmaceuticals Inc
- Remd Biotherapeutics Inc
- Repare Therapeutics Inc
- Rescue Therapeutics Inc
- Respiratorius AB
- Rhizen Pharmaceuticals SA
- Ribon Therapeutics Inc
- Rock Immune LLC
- Ryvu Therapeutics SA
- SA Science Inc
- Sana Biotechnology Inc
- Sangamo Therapeutics Inc
- Sano Chemicals Inc
- Sanofi
- Sareum Holdings Plc
- Schrodinger Inc
- SciTech Development LLC
- Score Pharma Inc
- Seagen Inc
- Secura Bio Inc
- selectION Inc
- SELLAS Life Sciences Group Inc
- Senhwa Biosciences Inc
- Sentinel Oncology Ltd
- Serb SAS
- Shandong New Time Pharmaceutical Co Ltd
- Shandong Qidu Pharmaceutical Co Ltd
- Shanghai Bioray Laboratory Inc
- Shanghai Cell Therapy Group Co
- Shanghai First Song Therapeutics Co Ltd
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
- Shanghai GeneChem Co Ltd
- Shanghai Haihe Biopharma Co Ltd
- Shanghai Haiyan Pharmaceutical Technology Co Ltd
- Shanghai Henlius Biotech Inc
- Shanghai Institute of Biological Products Co Ltd
- Shanghai Junshi Bioscience Co Ltd
- Shanghai Longyao Biotechnology Co Ltd
- Shanghai Meizer Pharmaceuticals Co Ltd
- Shanghai Miracogen Inc
- Shanghai Novamab Biopharmaceuticals Co Ltd
- Shanghai Pharmaceutical Group Co Ltd
- Shanghai Pharmaceuticals Holding Co Ltd
- Shanghai Simnova Biotechnology Co Ltd
- Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
- Shanghai YaKe Biotechnology Co Ltd
- Shanghai Yingli Pharmaceutical Co Ltd
- Shattuck Labs Inc
- Shengke Pharmaceuticals (Jiangsu) Ltd
- Shennong Biotech Inc
- Shenogen Pharma Group Ltd
- Shenzhen BinDeBio Ltd
- Shenzhen Chipscreen Biosciences Co Ltd
- Shenzhen Salubris Pharmaceuticals Co Ltd
- Shenzhen Targetrx Inc
- Shouyao Holding Co Ltd
- Sian Wuhan Medical Technology Co Ltd
- SideROS
- SignalRx Pharmaceuticals Inc
- Simcere Pharmaceutical Group Ltd
- Sino Biopharmaceutical Ltd
- SinoMab Bioscience Ltd
- SIRPant Immunotherapeutics Inc
- Solasia Pharma KK
- Soligenix Inc
- Sonoval LLC
- Sorrento Therapeutics Inc
- SpecificiT Pharma Inc
- Spectrum Pharmaceuticals Inc
- Step Pharma
- StingInn LLC
- SumiQ Therapeutics BV
- Shenghe (China) Biopharmaceutical Co Ltd
- Sunnycell Therapeutics Ltd
- Supratek Pharma Inc
- Sutro Biopharma Inc
- Suzhou Dingfu Target Biotechnology Co Ltd
- Suzhou Fundamenta Therapeutics Co Ltd
- Suzhou JiSheng Pharmaceutical Co Ltd
- Suzhou Maximum Bio-tech Co Ltd
- Syncopation Life Sciences Inc
- Syros Pharmaceuticals Inc
- Systimmune Inc
- Tachyon Therapeutics Inc
- Tacitus Therapeutics Inc
- Taiwan Liposome Co Ltd
- Takara Bio Inc
- Takeda Pharmaceutical Co Ltd
- Tango Therapeutics Inc
- Tayu Huaxia Biotech Medical Group Co Ltd
- TC BioPharm Ltd
- TCR Cure Biopharma Technology Co Ltd
- TCR2 Therapeutics Inc
- Telios Pharma Inc
- Tessa Therapeutics Ltd
- Tiannuojiancheng Pharma
- Tianweiyuan and Biomedicine Shanghai Co Ltd
- Timmune Biotech Inc
- TOT Biopharm Co Ltd
- Transgene Biotek Ltd
- Transgene SA
- TransThera Sciences (Nanjing) Inc
- Triphase Accelerator Corp
- Truvitech LLC
- Tubulis GmbH
- Turning Point Therapeutics Inc
- Tyme Inc
- Ubix Therapeutics Inc
- United BioPharma Inc
- UWELL Biopharma Inc
- Verismo Therapeutics
- Vidac Pharma
- Vincerx Pharma Inc
- Viracta Therapeutics Inc
- Viridian Therapeutics Inc
- Vivolux AB
- VM Discovery Inc
- Vyriad Inc
- Waterstone Hanxbio Pty Ltd
- Wellington Zhaotai Therapies Ltd
- Wigen Biomedicine Technology (Shanghai) Co Ltd
- Wugen Inc
- Wuhan Bio-Raid Biotechnology Co Ltd
- Wyze Biotech Co Ltd
- X4 Pharmaceuticals Inc
- Xcovery Holding Co LLC
- XEME BioPharma Inc
- Xencor Inc
- Xenetic Biosciences Inc
- Xi'An Yufan Biotechnology Co Ltd
- Xiconic Pharmaceuticals LLC
- Xynomic Pharmaceuticals Holdings Inc
- Xyphos Biosciences Inc
- Zentalis Pharmaceuticals Inc
- Zhejiang Borui Biopharmaceutical Co Ltd
- Zhejiang DTRM Biopharma LLC
- Zhejiang Hisun Pharmaceutical Co Ltd
- Zhejiang Landun Pharmaceutical Co Ltd
- Zhejiang Longchuan Biomedical Technology Co Ltd
- Zhejiang Teruisi Pharmaceutical Co Ltd
- Zhengda Tianqing Pharmaceutical Group Co Ltd
- Zhuobo Yong Ji (Shanghai) Biological Pharmaceutical Co Ltd
- Zibo Baiji Changsheng Pharmaceutical Co Ltd
- Zylem Biosciences Inc
